Rabies Vaccine (Vero Cell) (Changchun Werersai)

Changchun Werersai Rabies Vaccine (Vero Cell) is an inactivated viral vaccine developed for rabies post-exposure prophylaxis and prevention. It is produced by Changchun Werersai Biotech Pharmaceutical using Vero cell culture technology, which involves growing the rabies virus in a continuous lineage of mammalian cells before inactivation and purification. The vaccine is typically formulated as a freeze-dried powder for reconstitution and intramuscular injection. It is designed to elicit a protective immune response, specifically the production of virus-neutralizing antibodies (VNA), to prevent the onset of rabies following exposure. Clinical development has included Phase 3 trials in China evaluating its safety and immunogenicity compared to established vaccines using standard dosing schedules such as the Essen regimen.

Brand names

Changchun Werersai

Other names

Freeze-dried human rabies vaccine (Vero cell)Changchun Werersai Rabies Vaccine